Deep brain stimulation and the ethics of protection and caring for the patient with Parkinson's dementia

Movement Disorders

Volumn 23, Issue 14, 2008, Pages 1973-1976

  Farris, Sierra ^a,d   Ford, Paul ^b   DeMarco, Joseph ^c   Giroux, Monique L ^a  

^a Evergreen Hospital Medical Center   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CLEVELAND STATE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Deep brain stimulation; Dementia; Ethical; Parkinson's disease; Surrogate decision making

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

AGED; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; COGNITIVE DEFECT; DEMENTIA; FALLING; FEMALE; GENERAL ANESTHESIA; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL ETHICS; MOTOR PERFORMANCE; NERVE STIMULATION; NEUROPSYCHOLOGICAL TEST; NEUROSURGERY; NURSING HOME; PARKINSON DISEASE; PATIENT CARE; PATIENT SAFETY; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SUBTHALAMIC NUCLEUS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; WAKEFULNESS;

AGED; DEEP BRAIN STIMULATION; DEMENTIA; FEMALE; HUMANS; MALE; PARKINSON DISEASE;

EID: 57049128198     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22244     Document Type: Article

References (15)

1. Rodriguez RL, Fernandez HH, Haq I, Okun MS. Pearls in patient selection for deep brain stimulation. Neurologist 2007;13:253-260.
2. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. The New England journal of medicine 2003;349:1925-1934.
3. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 14):S290-S304.
4. Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002;17(Suppl 3): S94-S101.
5. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
6. Paluzzi A, Belli A, Bain P, Liu X, Aziz TM. Operative and hardware complications of deep brain stimulation for movement disorders. British journal of neurosurgery 2006;20:290-295.
7. Marder K, Tang MX, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995;52:695-701.
8. Kubu CS, Ford PJ. Ethics in the clinical application of neural implants. Camb Q Healthc Ethics 2007;16:317-321.
9. Ford PJ. Neurosurgical implants: clinical protocol considerations. Camb Q Healthc Ethics 2007;16:308-311.
10. Hariz MI, Krack P, Melvill R, et al. A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 2003;80(1-4):96-101.
11. Herzog J, Volkmann J, Krack P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 2003;18:1332-1337.
12. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:834-839.
13. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128(Part 10):2240-2249.
14. Beauchamp T, Childress J. Principles of biomedical ethics. 5th Edition. New York: Oxford University Press; 2001.
15. Ford PJ, Kubu CS. Stimulating debate: ethics in a multidisciplinary functional neurosurgery committee. 2006;32:106-109.